MAMSTR
MEF2-activating motif and SAP domain-containing transcriptional regulator
Also known as: FLJ36070, MASTR, MASTR_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q6ZN01
- Gene
- MAMSTR
- Ensembl
- ENSG00000176909
- Chromosome
- 19
- Canonical length
- 415 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nuclear speckles
OverviewNCBI Gene
Predicted to enable transcription coregulator activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to act upstream of or within positive regulation of myotube differentiation and positive regulation of transcription by RNA polymerase II. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
415 residues, UniProt reviewed canonical sequence.
>Q6ZN01|MAMSTR
1 MTLAASSQRS QIIRSKFRSV LQLRIHRRNQ EQISDPDPWI SASDPPLAPA LPSGTAPFLF
61 SPGVLLPEPE YCPPWRSPKK ESPKISQRWR ESKPRGNLTY HQYMPPEPRQ GSRADPQAEG
121 SALGPPGPSL WEGTDSQQPH PRMKPSPLTP CPPGVPSPSP PPHKLELQTL KLEELTVSEL
181 RQQLRLRGLP VSGTKSMLLE RMRGGAPPRE RPKPRREDSP AGAPWPRLKP KALAAARRQG
241 SVKPSAASHR PPLPRAADTP GTAPAPTPTP APAAAPALTP SSGPGSAALT LEEELQEAIR
301 RAQLLPNRGI DDILEDQVEP DDPLPPIPLD FPGSFDVLSP SPDSEGLSSV FSSSLPSPTN
361 SSSPSPRDPT DSLDWLEALS GGPPLGSGPP PPSIFSADLS DSSSSRLWDL LEDPWLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MAMSTR can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.65
- Highest tissue expression
- 83 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 83 nTPM
- adrenal gland: 31 nTPM
- tongue: 21 nTPM
- endometrium: 11 nTPM
- fallopian tube: 9.4 nTPM
- testis: 8.9 nTPM
Single-cell type
- myonuclei: 271 nCPM
- adrenal cortex cells: 109 nCPM
- granulosa cells: 58 nCPM
- sertoli cells: 21 nCPM
- gonadotrophs: 16 nCPM
- mesothelial cells: 16 nCPM
Immune cell
- naive B-cell: 2.1 nTPM
- memory CD4 T-cell: 1.7 nTPM
- naive CD4 T-cell: 1.7 nTPM
- gdT-cell: 1.6 nTPM
- memory CD8 T-cell: 1.6 nTPM
- naive CD8 T-cell: 1.5 nTPM
Brain region
- cerebellum: 22 nTPM
- cerebral cortex: 11 nTPM
- amygdala: 9 nTPM
- hippocampal formation: 8.8 nTPM
- basal ganglia: 8.7 nTPM
- white matter: 7.9 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.84
- gnomAD pLI
- 0.01
- gnomAD missense Z
- 0.57
- DepMap mean gene effect
- -0.03
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- positive regulation of myotube differentiation
- positive regulation of transcription by RNA polymerase II
- regulation of transcription by RNA polymerase II
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of MAMSTR in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MAMSTR as an antibody target. Whether an autoantibody or antibody against MAMSTR could matter depends on whether native MAMSTR is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MAMSTR is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MAMSTR as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...